CVS Health Posts Strong Guidance, Raises Its Dividend, and Flags New InitiativesInvestopedia • 12/05/23
CVS to overhaul drug-pricing model to boost transparency amid scrutiny of high cost for medsNew York Post • 12/05/23
CVS Health's stock pops 3% after it offers above-consensus revenue guidance for 2024Market Watch • 12/05/23
CVS Health highlights path to accelerating long-term growth through building a world of health around every consumerPRNewsWire • 12/05/23
CVS holds still on update, CMA update in early 2024 remains key say analystsProactive Investors • 11/29/23